{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Colchicine-Site_Binding_Agent_ABT-751",
  "nciThesaurus": {
    "casRegistry": "141430-65-1",
    "chebiId": "",
    "chemicalFormula": "",
    "definition": "An orally bioavailable antimitotic sulfonamide. ABT- 751 binds to the colchicine-binding site on beta-tubulin and inhibits the polymerization of microtubules, thereby preventing tumor cell replication. This agent also disrupts tumor neovascularization, reducing tumor blood flow and so inducing a cytotoxic effect.",
    "fdaUniiCode": "WDT5V5OB9F",
    "identifier": "C2679",
    "preferredName": "Colchicine-Site Binding Agent ABT-751",
    "semanticType": "Organic Chemical",
    "subclassOf": [
      "C67421"
    ],
    "synonyms": [
      "ABT-751",
      "Colchicine-Site Binding Agent ABT-751",
      "E 7010",
      "E-7010",
      "E7010",
      "N-[2-[(4-Hydroxyphenyl)amino]-3-pyridinyl]-4-methoxybenzenesulfonamide"
    ]
  }
}